Hemostatic agents help reduce blood loss and save lives.
The operating room involves a team of highly skilled clinicians where every minute counts in helping patients undergoing surgery. Controlling bleeding in a quick and efficient manner helps minimise blood loss and allows more efficient utilisation of valuable operating room time. Many common wounds like necrotic and chronic wounds requiring particularly aggressive post sharp debridement require a fast acting hemostat like OMNI-STAT®.
OMNI-STAT® is a topical temporary external hemostat that helps rapidly and safely stop bleeding. It is effective for patients using common anti-coagulant drugs (Millner, 2010, Koksal, 2011 & Data on file). Rapid hemostasis may allow for shorter patient operating times leading to better management of valuable staff resources and also helping to reduce blood loss and any associated risks.
- Fast Acting Stops bleeding in as little as 1 minute (In vitro & in vivo data) and significantly reduces OR time (Thibodeaux et al).
- Proven effective in the presence of common anticoagulants (Johnston et al, Snyder et al) and in hypothermic conditions (In vitro & in vivo data).
- Safe No reported adverse events including allergic reactions (MT-20-310 Allergenicity Potential of Celox. Omni-Stat Hemostatic Devices Position Statement).
- Product range for minor wounds to severe arterial bleeding.
Hemostats that work independent of the body’s natural clotting cascade may offer benefits to patients with impaired coagulation.
For temporary topical external control of minor, moderate and severe bleeding. Omni-Stat is also for control associated with minor wounds including control of minor external bleeding and exudate from sutures and/or surgical procedures.
OMNI-STAT® is Proven to Reduce Total Procedure Time and OR Time (Thibodeaux et al)
• Equally as effective as electrocautery
• Significant (30.4%) reduction in Procedure Time and OR Time (19.1%)
• Potential for increased cost effectiveness by increasing the number of surgical cases
• Better quality of re-epithelialization observed vs electrocautery